Consult an Expert
Trademark
Design Registration
Consult an Expert
Trademark
Copyright
Patent
Infringement
Design Registration
More
Consult an Expert
Consult an Expert
Trademark
Design Registration
Login
D
DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events
ASTRAZENECA AB,
DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events is a Trademark filed on Jun 27, 2012 in through IP Office.The Trademark is registered to ASTRAZENECA AB, and was filed by attorney.
D
DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events ASTRAZENECA AB, Trademark Information
Application ID
2354861
Status
Objected
Date of Application
Jun 27, 2012
Classes
42
Proprietor(s)
ASTRAZENECA AB,
FAQ's for DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events ASTRAZENECA AB, Trademark
The application for DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events was made on Jun 27, 2012
The trademark applicant for DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events is ASTRAZENECA AB,.
Trademark application has been filed under the class(es) 42.
As per IP India, trademark application is on the following stage: Objected.
Listed application Id of DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events is 2354861.
DECLARE Dapagliflozin Evaluation of CardiovascuLAR Events Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
Don’t lose your brand like ””
Our experts are here to assist you in finding a similar trademark.
Our experts are here to assist you in finding a similar trademark.
4.5
(18k+ reviews)
1 Lakh+
TM Registered since 2011
